Search Results

Oral capecitabine more efficacious than IV 5-FU/LV in treating colon cancer.

• Source: Formulary. 2004, Vol. 39, Issue 11, pages. 529

Record details

Oral capecitabine more efficacious than IV 5-FU/LV in treating colon cancer.

• Source: Formulary. Nov2004, Vol. 39 Issue 11, p529-530. 2p.

Record details

A black box has been added to labeling for the cancer therapy capecitabine.

• Source: Formulary. 2001, Vol. 36, Issue 12, pages. 830

Record details

Xeloda.

• Source: Formulary. 2001, Vol. 36, Issue 7, pages. 481

Record details

Approvable designations.

• Source: Formulary. 2000, Vol. 35, Issue 11, pages. 867

Record details

New Indications: Xeloda.

Subjects: ANTINEOPLASTIC agents; COLON cancer; DRUG side effects

• Source: Formulary. Jul2001, Vol. 36 Issue 7, p481. 1/2p.

Record details

Pipeline preview.

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p214-214. 2p.

Record details

New molecular entities: Tykerb.

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p214-215. 2p.

Record details

New biologic: Soliris.

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p215-216. 2p.

Record details

New molecular entities.

• Source: Formulary. Dec2007, Vol. 42 Issue 12, p661-663. 3p.

Record details